Testing a home-use hepatitis C test with adults
Part of Digestive system, Infections clinical trials.
This trial tests a home-use test for hepatitis C (HCV) to see if people can use it correctly without help. It is for adults who are not healthcare workers or in other studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are willing to follow the study steps and give your permission to participate.
- You are not a healthcare professional, lab scientist, or technician, and you have no medical or lab training.
- You have not already taken part in this study before.
- You are not currently in another study for an experimental drug or vaccine.
- You can read the instructions (with glasses or contacts if needed) and do not have a vision problem that can't be fixed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.
This study is setting up a program to test adults for hepatitis C antibodies using quick, point-of-care tests. It helps confirm how well this testing approach works in real-world care so more people can be identified and treated earlier.
This study collects basic information from adults who already had a quick, on-site hepatitis C (HCV) test. It aims to improve how point-of-care testing is done and documented, which may lead to faster follow-up and care.
This study looks at what patients think about and are willing to use a quick “point-of-care” blood test for hepatitis C virus (HCV) after a positive antibody screen. It may help the ER find people with possible active infection faster and improve how testing is offered.
This trial tests a new protein-based vaccine to prevent hepatitis C. It is for healthy, non-smoking adults aged 18-45 who are up to date on their flu and COVID-19 vaccines.
This study is testing a tool to find people who may be at risk for or already have HIV or hepatitis C. It aims to connect them with care and support.
Hear when a new Hepatitis C trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.